Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.930
+0.030 (1.58%)
Jun 6, 2025, 4:00 PM - Market closed
APUS Statistics
Total Valuation
APUS has a market cap or net worth of $22.34 million. The enterprise value is $23.06 million.
Market Cap | 22.34M |
Enterprise Value | 23.06M |
Important Dates
The last earnings date was Tuesday, May 20, 2025, before market open.
Earnings Date | May 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
APUS has 11.58 million shares outstanding. The number of shares has increased by 40.82% in one year.
Current Share Class | 11.58M |
Shares Outstanding | 11.58M |
Shares Change (YoY) | +40.82% |
Shares Change (QoQ) | -0.00% |
Owned by Insiders (%) | 19.62% |
Owned by Institutions (%) | 1.73% |
Float | 2.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
Current Ratio | 0.15 |
Quick Ratio | 0.14 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -10.62 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -409.38% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 90.55% |
Revenue Per Employee | n/a |
Profits Per Employee | -$747,957 |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 43.98 |
Average Volume (20 Days) | 195,927 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.37M |
Pretax Income | -1.42M |
Net Income | -1.50M |
EBITDA | n/a |
EBIT | -1.37M |
Earnings Per Share (EPS) | -$0.19 |
Balance Sheet
The company has $250,342 in cash and $967,320 in debt, giving a net cash position of -$716,978 or -$0.06 per share.
Cash & Cash Equivalents | 250,342 |
Total Debt | 967,320 |
Net Cash | -716,978 |
Net Cash Per Share | -$0.06 |
Equity (Book Value) | -1.76M |
Book Value Per Share | -0.22 |
Working Capital | -1.51M |
Cash Flow
Operating Cash Flow | -490,739 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
APUS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -40.82% |
Shareholder Yield | -40.82% |
Earnings Yield | -6.70% |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |